Ozempic vs Mounjaro — Side-by-side comparison of semaglutide and tirzepatide pens on a medical scale

On this page

    Ozempic vs Mounjaro: Weight Loss, Dosing & Cost

    Verdict

    Mounjaro is the clinical winner for weight loss. In head-to-head comparisons of Ozempic vs Mounjaro, the dual-agonist formula (tirzepatide) led to ~21% weight loss versus ~15% for Ozempic (semaglutide). However, Ozempic is often easier to cover with insurance for Type 2 Diabetes. For cash-pay patients, both are expensive brand-name options (~$900–$1,200/mo), though compounded alternatives exist for significantly less.12

    E

    Medical Fact-Check

    • Which loses more weight? Mounjaro (Tirzepatide) wins in clinical trials (~6% greater loss).3
    • Can I switch? Yes. Switching is common to break plateaus; you must re-titrate slowly.
    • What is the price difference? Retail cash prices are similar (~$1,000+). Compounded versions save ~70%.

    Safety first: Both medications carry Black Box Warnings for thyroid C-cell tumors (in rodents). Do not use if you have a family history of MTC or MEN2. Common side effects include nausea and GI distress.45

    Ozempic vs Mounjaro — Side-by-side comparison of 
 semaglutide and tirzepatide pens on a medical scale
    Mounjaro targets two hormone receptors, while Ozempic targets one.

    Which loses more weight? (Head-to-Head)

    While both drugs are effective, Mounjaro (tirzepatide) has demonstrated superior weight loss results in clinical trials compared to Ozempic (semaglutide). The key difference is the mechanism: Ozempic mimics one hormone (GLP-1), while Mounjaro mimics two (GLP-1 + GIP).

    Ozempic vs Mounjaro — Bar chart showing Mounjaro leads to ~21% weight loss vs ~15% for Ozempic
    Trials show Mounjaro leads to higher average weight loss at maintenance doses.
    Feature Ozempic (Semaglutide) Mounjaro (Tirzepatide)
    Avg. Weight Loss ~15% (at 68 weeks)4 ~21% (at 72 weeks)3
    Mechanism Single Agonist (GLP-1) Dual Agonist (GIP + GLP-1)
    FDA Status Type 2 Diabetes Type 2 Diabetes
    Data from STEP-1 and SURMOUNT-1 trials. Individual results vary.
    Ozempic targets one hormone; Mounjaro targets two. Watch the 60-second breakdown.

    Watch on YouTube

    How do they work? (The Dual-Agonist Difference)

    The main scientific difference is the "GIP" hormone. Ozempic mimics one hormone (GLP-1) to signal fullness. Mounjaro adds a second hormone (GIP) which is thought to improve how the body breaks down sugar and fat, creating a synergistic effect.

    Ozempic vs Mounjaro — Illustration showing Ozempic as a single GLP-1 agonist and Mounjaro as a dual GLP-1 and GIP agonist
    Single-receptor targeting (Ozempic) vs Dual-receptor targeting (Mounjaro).

    Price Fight: Is Mounjaro worth the cost?

    Both medications are expensive if you are paying cash (retail prices often exceed $1,000/month). Insurance coverage is the great equalizer—if you are covered, your co-pay may be as low as $25. If you are not covered, compounded alternatives are significantly cheaper.

    Cash-Pay Pricing at a Glance

    Brand
    Month-1 (Cash)~$1,799
    Month-2+ (Care)~$145
    Medication~$900+

    Note: High retail variance. Compounded options start around $249/mo.

    Brand
    Month-1 (Cash)~$1,899
    Month-2+ (Care)~$145
    Medication~$1,000+

    Note: Compounded tirzepatide options start around $449/mo.

    Pricing source: Composite average of telehealth retail prices (Hims, Ro) and coupon estimates.5

    Which has worse side effects?

    Both medications share a similar side effect profile, primarily gastrointestinal (GI) issues. Because Mounjaro targets two receptors, some patients report different tolerability, but clinical data shows rates are comparable.

    Side Effect Ozempic Frequency Mounjaro Frequency
    Nausea ~15–20% ~12–18%
    Diarrhea ~9% ~12–15%
    Vomiting ~5–9% ~4–9%
    Rates from PI labels. Slow titration helps mitigate these effects.12

    Can I switch from Ozempic to Mounjaro?

    Yes, many patients switch from Ozempic to Mounjaro (or vice versa) to break a weight loss plateau or manage side effects. This is safe but requires a "reset" period.

    • The Washout: Your clinician may recommend waiting 1–2 weeks between your last Ozempic dose and first Mounjaro dose.
    • Restart Low: You typically cannot jump from max-dose Ozempic (2.0mg) to max-dose Mounjaro (15mg). You will likely restart at Mounjaro 2.5mg or 5mg to let your body adjust to the new GIP hormone mechanism.

    Availability & Shortages

    Both drugs have faced intermittent shortages due to high demand. As of late 2025, availability fluctuates by dose strength. Compounded versions (made by regulated 503B/503A pharmacies) have become a primary alternative during FDA-listed shortages.6

    Is Mounjaro stronger than Ozempic?

    Yes. Data from the SURMOUNT-1 trial suggests Mounjaro leads to roughly 6% more total body weight loss than Ozempic on average, likely due to its dual-agonist (GIP + GLP-1) action.3

    Can I take both together?

    No. Stacking GLP-1 medications increases the risk of severe side effects like pancreatitis and hypoglycemia. Never combine them.

    Why is Mounjaro more expensive?

    Mounjaro is a newer medication (first-in-class dual agonist) with high demand, keeping its retail list price slightly higher (~$1,069 vs ~$968 for Ozempic) in many pharmacies.

    Medical Disclaimer: This content is for educational purposes only and has been verified against clinical data for accuracy. It does not constitute medical advice, diagnosis, or treatment. Always consult your prescriber or healthcare provider before starting or changing any GLP-1 medication regimen.

    References

    1. Novo Nordisk. Ozempic (semaglutide) Prescribing Information. View source
    2. Eli Lilly. Mounjaro (tirzepatide) Prescribing Information. View source
    3. Jastreboff AM, et al. SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022. View source
    4. Wilding JPH, et al. STEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. View source
    5. Frias JP, et al. SURPASS-2: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021. View source
    6. U.S. FDA. FDA Drug Shortages Database. View source

    📚 You Might Also Like

    Related Articles

    How to get a GLP-1 prescription - Illustration showing PCP, Specialist, and Telehealth paths
    Navigating the "Name Game" of weight loss drugs is confusing. We break down the three paths to a prescription (PCP, Specialist, Telehealth), how to
    A flat vector illustration showing a person's mind overwhelmed by chaotic thought bubbles of junk food and static, representing intrusive food noise.
    Food noise is a biological signaling error in the brain's reward center, not a personality flaw. Learn the neuroscience behind food obsession and why
    Ozempic split dosing schedule comparison showing a standard single weekly injection versus a risky split timeline
    Split dosing Ozempic is a patient-led hack to manage "Day 5 Hunger Noise," but it relies on uncalibrated pen clicks and violates the 56-day